Plain-English translation of NCT07131735 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →Researchers are testing a new device that uses artificial intelligence to detect breast cancer during surgery by analyzing gases released when tissue is cauterized with electrosurgery. The device is trained to recognize the unique chemical fingerprint of cancer cells versus healthy tissue. If successful, this technology could help surgeons see cancer margins more clearly in real time during breast-conserving surgery.
During breast cancer surgery, it can be difficult for surgeons to know whether all the cancer has been removed while the patient is still in the operating room. This test could provide immediate feedback about whether the tissue being removed is cancerous, potentially reducing the need for repeat surgeries and improving surgical outcomes.
You likely qualify if…
You likely don't qualify if…
During your scheduled breast cancer surgery, a small tube will be connected to the surgical smoke extractor to collect gases released during the procedure—this won't change your surgery or add extra time. After surgery, your tissue samples will be tested in the lab and compared to what the device detected. You'll then be followed for 2 years through your regular medical appointments at UC Christus to watch for any cancer recurrence and see how well the device performed.
AI-generated summary from trial data · Sep 4, 2026 · Not medical advice
Chile